Julia Leongardovna Tonkikh

Julia Leongardovna Tonkikh

Auto-generated profile, based on publicly available information

Julia Leongardovna Tonkikh

Federal Research Center “Krasnoyarsk Science Center” of the Siberian Branch of the Russian Academy of Sciences, Scientific Research Institute of Medical Problems of the North, 660022 Krasnoyarsk, Russia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
Vladislav Vladimirovich TsukanovVladislav Vladimirovich Tsukanov
Vladislav Vladimirovich Tsukanov
OSOlga Valentinovna Smirnova
Olga Valentinovna Smirnova
EKEdward Vilyamovich Kasparov
Edward Vilyamovich Kasparov
ASAleksandr Sinyakov
Aleksandr Sinyakov
AVAlexander Viktorovich Vasyutin
Alexander Viktorovich Vasyutin
MCMikhail Alexandrovich Cherepnin
Mikhail Alexandrovich Cherepnin
Gastric cancer is a global health problem. The pathogenesis of this disease remains unclear. This study included 198 H. pylori (+) men aged 45 to 60 years old. Group A included 63 practically healthy men, group B included 45 men with severe atrophic body gastritis, group C included 37 men with epithelial gastric cancer stages I–II according to TNM, and group D included 54 men with epithelial gastric cancer stages III–IV according to the TNM scale. The content of malondialdehyde (MDA), diene conjugates (DCs), superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), and glutathione peroxidase (GPO) was detected using an enzyme immunoassay (ELISA) or spectrophotometric methods in the blood plasma. The concentrations of MDA and DC were increased in the patients of group B compared with group A, and in patients of groups C and D compared with groups A and B. The ratio of MDA/SOD and MDA/CAT was decreased in the patients in group D compared with the patients in group C, and was significantly higher compared with group A. The ratios of MDA/GPO and MDA/GST increased linearly and were at a maximum in groups C and D. Our work determined that indicators of oxidative stress may be the biochemical substrate, which brings together the various stages of the Correa cascade, and may explain disease progression. The dynamics of changes in the content of SOD and CAT in the plasma in patients with gastric cancer may be a target of future investigations.

1 January 2019 in Doctor.Ru
Verified
Journal Article
Open access
Vladislav Vladimirovich TsukanovVladislav Vladimirovich Tsukanov
Vladislav Vladimirovich Tsukanov
YTYu.L. Tonkikh
Yu.L. Tonkikh
AGA.V. Gilyuk
A.V. Gilyuk
KHKrasnoyarsk Railway Station of RZhD JSC; Russian Federation Railway Clinical Hospital
Krasnoyarsk Railway Station of RZhD JSC; Russian Federation Railway Clinical Hospital
AVA.V. Vasyutin
A.V. Vasyutin
KCKrasnoyarsk Panakea Medical Centre
Krasnoyarsk Panakea Medical Centre
Диагностика, клиника и лечение описторхоза

1 January 2019 in Doctor.Ru
Verified
Journal Article
Open access
SSScientific and Research Institute of Medical Problems of the North of the Federal Research Centre “Krasnoyarsk Scientific Centre of the Siberian Branch of the Russian Academy of Science”
Scientific and Research Institute of Medical Problems of the North of the Federal Research Centre “Krasnoyarsk Scientific Centre of the Siberian Branch of the Russian Academy of Science”
Vladislav Vladimirovich TsukanovVladislav Vladimirovich Tsukanov
Vladislav Vladimirovich Tsukanov
AVA.V. Vasyutin
A.V. Vasyutin
YTYu.L. Tonkikh
Yu.L. Tonkikh
EOE.V. Onuchina
E.V. Onuchina
EPE.A. Platonova
E.A. Platonova
Бремя заболеваний печени в современном мире. Некоторые показатели качества ведения больных с циррозом печени в Сибирском федеральном округе

21 February 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
Vladislav Vladimirovich TsukanovVladislav Vladimirovich Tsukanov
Vladislav Vladimirovich Tsukanov
ASAndrei Savchenko
Andrei Savchenko
MCMikhail Aleksandrovich Cherepnin
Mikhail Aleksandrovich Cherepnin
EKEduard Vilyamovich Kasparov
Eduard Vilyamovich Kasparov
ETElena Petrovna Tikhonova
Elena Petrovna Tikhonova
ABAlexandr Gennadyevich Borisov
Alexandr Gennadyevich Borisov
Background: NK cells phenotype and functional state in different genotypes of chronic viral hepatitis C (CVHC), depending on liver fibrosis severity, have not been sufficiently studied, which limits the possibilities for the development of pathology therapy. Methods: The CVHC diagnosis was based on the EASL recommendations (2018). Clinical examination with liver elastometry was performed in 297 patients with genotype 1 and in 231 patients with genotype 3 CVHC. The blood NK cells phenotype was determined by flow cytometry in 74 individuals with genotype 1 and in 69 individuals with genotype 3 CVHC. Results: The frequency of METAVIR liver fibrosis stages F3–F4 was 32.5% in individuals with genotype 3, and 20.5% in individuals with genotype 1 CVHC (p = 0.003). In patients with both genotype 1 and genotype 3 CVHC, a decrease in the total number of blood NK cells, CD56brightCD16+ NK cells and an increase in the proportion of CD56dimCD16+ NK cells, CD94+ and CD38 + CD73+ NK cells were registered in patients with fibrosis stage F3–F4 by METAVIR in comparison with persons with METAVIR fibrosis stage F0–F1. Conclusions: In patients with both genotype 1 and genotype 3 CVHC, an imbalance in the ratio between cytokine-producing and cytotoxic NK cells and an increase in the content of NK cells that express inhibitory molecules were determined in patients with severe liver fibrosis.

1 January 2019 in Doctor.Ru
Verified
Journal Article
Open access
Vladislav Vladimirovich TsukanovVladislav Vladimirovich Tsukanov
Vladislav Vladimirovich Tsukanov
SSScientific and Research Institute of Medical Problems of the North of the Federal Research Centre “Krasnoyarsk Scientific Centre of the Siberian Branch of the Russian Academy of Science”
Scientific and Research Institute of Medical Problems of the North of the Federal Research Centre “Krasnoyarsk Scientific Centre of the Siberian Branch of the Russian Academy of Science”
AVA.V. Vasyutin
A.V. Vasyutin
YTYu.L. Tonkikh
Yu.L. Tonkikh
Современные принципы ведения пациентов с неалкогольной жировой болезнью печени

28 January 2020 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
Vladislav Vladimirovich TsukanovVladislav Vladimirovich Tsukanov
Vladislav Vladimirovich Tsukanov
EOE. V. Onuchina
E. V. Onuchina
AVA. V. Vasyutin
A. V. Vasyutin
YTYu. L. Tonkikh
Yu. L. Tonkikh
ЮТЮ. Л. Тонких
Ю. Л. Тонких
Objective of the study. A 5-year prospective study was aimed to evaluate the efficacy of Ursosan treatment for dissolving gallstones.Material and methods. Patients who had single gallbladder stones were randomized to group A, in which 47 people completed the study (16 men and 31 women, median age is 67.6 years), and group B – 41 people 14 men and 27 women, median age is 68, 1 years). All patients of group A continuously received continuous treatment with ursodeoxycholic acid drug Ursosan at a dose of 10 mg /kg per day for 5 years. The patients of group D did not receive Ursosan; these individuals received periodic courses of spasmodic drugs. The patients passed clinical examination, laboratory tests, transabdominal ultrasound of the liver and biliary tract before the study, 2 times a year for 5 years and after the study.Results. After 5 years of treatment, stones were detected in 10.6% of patients in group A. In group B, the incidence of gallstones did not change after 5 years of treatment, that is, calculi were detected in all patients (p <0.001). At the end of the study, no muldoi tiple stones were observed in any of the patients of group A, while multiple stones were detected in 2/3 of group B patients after 5 years of treatment. A distinct decrease in pain syndrome frequency and improvement in contractile function of the gallbladder were recorded in patients of group A as compared to the patients of group B by the end of the observation period. The side effect profile did not differ in groups A and B. The study showed good tolerance of Ursosan for 5 years of continuous administration of the drug.Findings. The 5-year prospective study showed that Ursosan’s efficacy in dissolving gallstones accounted for 90%. Ursosan also prevented the formation of new calculi and reduced the frequency of pain, improved the gall-bladder contractile function and reduced the need for cholecystectomy by the end of the observation period.